| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10916011 | Nuclear Medicine and Biology | 2014 | 7 Pages |
Abstract
The favorable pharmacokinetics and enhanced tumor uptake of 64Cu-NOTA-RGD-Glu-6Ahx-RM2 warrant further investigations for dual integrin and GRPr-positive tumor imaging and possible radiotherapy.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
![A heterodimeric [RGD-Glu-[64Cu-NO2A]-6-Ahx-RM2] αvβ3/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumors](/preview/png/10916011.png "First Page Preview: A heterodimeric [RGD-Glu-[64Cu-NO2A]-6-Ahx-RM2] αvβ3/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumors")
Authors
Kubra Durkan, Zongrun Jiang, Tammy L. Rold, Gary L. Sieckman, Timothy J. Hoffman, Rajendra Prasad Bandari, Ashley F. Szczodroski, Liqin Liu, Yubin Miao, Tamila Stott Reynolds, Charles J. Smith,